Katapodi, M. C., Viassolo, V., Caiata-Zufferey, M., Nikolaidis, C., Bührer-Landolt, R., Buerki, N. G., Graffeo, R., Horváth, H. C., Kurzeder, C., Rabaglio, M., Scharfe, M., Urech, C., Erlanger, T. E., Probst-Hensch, N., Heinimann, K., Heinzelmann-Schwarz, V., Pagani, O. and Chappuis, P. O. (2017) “Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol”, JMIR Research Protocols. JMIR Publications, 6(9), p. e184. doi: 10.2196/resprot.8138.   edoc | Open Access
Katsara, A., Wight, E., Heinzelmann-Schwarz, V. and Kavvadias, T. (2016) “Long-term quality of life, satisfaction, pelvic floor symptoms and regret after colpocleisis”, Archives of gynecology and obstetrics, 294(5), pp. 999–1003. doi: 10.1007/s00404-016-4158-y.   edoc
Pochechueva, T., Chinarev, A., Schoetzau, A., Fedier, A., Bovin, N. V., Hacker, N. F., Jacob, F. and Heinzelmann-Schwarz, V. (2016) “Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients”, PLoS One, 11(10), p. e0164230. doi: 10.1371/journal.pone.0164230.   edoc
Manegold-Brauer, G., Buechel, J., Knipprath-Meszaros, A., Schoetzau, A., Hacker, N. F., Tercanli, S., Lapaire, O. and Heinzelmann-Schwarz, V. (2016) “Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting”, Int J Gynecol Cancer, 26(6), pp. 1062–1069. doi: 10.1097/IGC.0000000000000718.   edoc
Kohler, R. S., Anugraham, M., Lopez, M. N., Xiao, C., Schoetzau, A., Hettich, T., Schlotterbeck, G., Fedier, A., Jacob, F. and Heinzelmann-Schwarz, V. (2016) “Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients”, Oncotarget, 7(32), pp. 51674–51686. doi: 10.18632/oncotarget.10543.   edoc
Decollogne, S., Joshi, S., Chung, S. A., Luk, P. P., Yeo, R. X., Nixdorf, S., Fedier, A., Heinzelmann-Schwarz, V., Hogg, P. J. and Dilda, P. J. (2015) “Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells”, Gynecologic Oncology, 138(2), pp. 363–371. doi: 10.1016/j.ygyno.2015.06.018.   edoc
Henry, C., Llamosas, E., Knipprath-Meszaros, A., Schoetzau, A., Obermann, E., Fuenfschilling, M., Caduff, R., Fink, D., Hacker, N., Ward, R., Heinzelmann-Schwarz, V. and Ford, C. (2015) “Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion”, Oncotarget, 6(37), pp. 40310–40326. doi: 10.18632/oncotarget.5643.   edoc
Manegold-Brauer, G. and Heinzelmann-Schwarz, V. (2015) “Comment on the letter: the mass cannot be classified as malignant”, Archives of Gynecology and Obstetrics, 291(3), p. 475. doi: 10.1007/s00404-014-3558-0.   edoc
Anugraham, M., Jacob, F., Nixdorf, S., Everest-Dass, A. V., Heinzelmann-Schwarz, V. A. and Packer, N. H. (2014) “Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status ”, Molecular and Cellular Proteomics. American Society for Biochemistry and Molecular Biology, 13(9), pp. 2213–2232. doi: 10.1074/mcp.M113.037085.   edoc
Ford, C., Punnia-Moorthy, G., Henry, C. E., Llamosas, E., Nixdorf, S., Olivier, J., Caduff, R., Ward, R. L. and Heinzelmann-Schwarz, V. A. (2014) “The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer”, Gynecologic oncology. Elsevier, 134(2), pp. 338–345. doi: 10.1016/j.ygyno.2014.06.004.   edoc
Heinzelmann-Schwarz, V. A., Kind, A. B. and Jacob, F. (2014) “Management of human papillomavirus-related gynecological malignancies”, Current problems in dermatology. S. Karger, 45, pp. 216–224. doi: 10.1159/000358408.   edoc
Heinzelmann-Schwarz, V. A., Nixdorf, S., Valadan, M., Diczbalis, M., Olivier, J., Otton, G., Fedier, A., Hacker, N. F. and Scurry, J. P. (2014) “A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker”, International journal of molecular medicine. D.A. Spandidos, 33(4), pp. 784–794. doi: 10.3892/ijmm.2014.1659.   edoc
Jacob, F., Anugraham, M., Pochechueva, T., Tse, B. W. ., Alam, S., Guertler, R., Bovin, N. V., Fedier, A., Hacker, N. F., Huflejt, M. E., Packer, N. and Heinzelmann-Schwarz, V. A. (2014) “The glycosphingolipid P(1) is an ovarian cancer-associated carbohydrate antigen involved in migration”, British journal of cancer. Nature Publishing Group, 111(8), pp. 1634–1645. doi: 10.1038/bjc.2014.455.   edoc
Jacob, F., Hitchins, M. P., Fedier, A., Brennan, K., Nixdorf, S., Hacker, N. F., Ward, R. and Heinzelmann-Schwarz, V. A. (2014) “Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells”, BMC molecular biology. BioMed Central, 15, p. 24. doi: 10.1186/1471-2199-15-24.   edoc
Jacob, F., Nixdorf, S., Hacker, N. F. and Heinzelmann-Schwarz, V. A. (2014) “Reliable in vitro studies require appropriate ovarian cancer cell lines”, Journal of ovarian research. BioMed Central Ltd, 7, p. 60. doi: 10.1186/1757-2215-7-60.   edoc
Manegold-Brauer, G., Bellin, A. K., Tercanli, S., Lapaire, O. and Heinzelmann-Schwarz, V. (2014) “The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging”, Arch Gynecol Obstet. Springer, 289(3), pp. 491–498. doi: 10.1007/s00404-013-3081-8.   edoc
Martin, K. S., Müller, P., Schreiner, J., Prince, S. S., Lardinois, D., Heinzelmann-Schwarz, V., Thommen, D. S. and Zippelius, A. (2014) “The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity”, Cancer Immunology, Immunotherapy. Springer, 63(9), pp. 925–938. doi: 10.1007/s00262-014-1565-4.   edoc
Pochechueva, T., Chinarev, A. A., Bovin, N. V., Fedier, A., Jacob, F. and Heinzelmann-Schwarz, V. (2014) “PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension array”, Journal of immunological methods. Elsevier, 412, pp. 42–52. doi: 10.1016/j.jim.2014.06.015.   edoc
Schwab, F. D., Bürki, N., Huang, D. J., Heinzelmann-Schwarz, V., Schmid, S. M., Vetter, M., Schötzau, A. and Güth, U. (2014) “Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancer”, Familial cancer. Springer, 13(1), pp. 99–107. doi: 10.1007/s10689-013-9682-3.   edoc
Müller, P., Martin, K., Theurich, S., Schreiner, J., Savic, S., Terszowski, G., Lardinois, D., Heinzelmann-Schwarz, V. A., Schlaak, M., Kvasnicka, H. M., Spagnoli, G., Dirnhofer, S., Speiser, D. E., von Bergwelt-Baildon, M. and Zippelius, A. (2014) “Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells”, Cancer Immunology Research. American Association for Cancer Research (AACR), 2(8), pp. 741–755. doi: 10.1158/2326-6066.CIR-13-0198.   edoc
Tse, B. W., Collins, A., Oehler, M. K., Zippelius, A. and Heinzelmann-Schwarz, V. A. (2014) “Antibody-based immunotherapy for ovarian cancer: where are we at?”, Annals of oncology. Oxford University Press, Vol. 25, H. 2, pp. 322–331. doi: 10.1093/annonc/mdt405.   edoc